HOUT-07. AN EVALUATION OF THE TREATMENT COURSE IN PATIENTS WITH GLIOBLASTOMA MULTIFORME

INTRODUCTION: Glioblastoma multiforme (GBM) is a malignant brain tumor with a mean overall survival of 15 months using current treatment modalities. Previous studies have shown delays in treatment result in worse outcomes. Demographic and socioeconomic factors may have a role in treatment course var...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Dincer, Alper, Carr, Matthew, Ravindra, Lakshmi, Zhang, Fan, Hochheimer, Camille, Rock, Andrew, Opalak, Charles, Somasundaram, Aravind, Workman, Kathryn, Sima, Adam, Broaddus, William
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217019/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.475
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items